Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts

Last Updated: January 17, 2020

DrugPatentWatch Database Preview

Litigation Details for Millennium Pharmaceuticals Inc. v. Accord Healthcare Inc. (D. Del. 2012)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Millennium Pharmaceuticals Inc. v. Accord Healthcare Inc. (D. Del. 2012)

Docket   Start Trial Date Filed 2012-11-19
Court District Court, D. Delaware Date Terminated 2015-09-24
Cause 35:271 Patent Infringement Assigned To Gregory Moneta Sleet
Jury Demand None Referred To
Patents 6,713,446; 6,958,319
Attorneys Adam Wyatt Poff; Jack B. Blumenfeld; Maryellen Noreika
Link to Docket External link to docket
Small Molecule Drugs cited in Millennium Pharmaceuticals Inc. v. Accord Healthcare Inc.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Millennium Pharmaceuticals Inc. v. Accord Healthcare Inc. (D. Del. 2012)

Date Filed Document No. Description Snippet Link To Document
2012-11-19 1 BACKGROUND l7. United States Patent No. 6,713,446 (“the ’446 patent”), entitled “Formulation of Boronic…VELCADE® prior to the expiration of U.S. Patent Nos. 6,713,446 and 6,958,319. DLIES 2. Plaintiff Millennium…the Notice Letter. M INFRINGEMENT oF U.s. PATENT No. 6.713,446 28. Plaintiff incorporates each of the … ACTION l. This is an action for patent infringement under the patent laws of the United States, Title…January 25, 2022. 18. United States Patent No. 6,958,319 (“the ’319 patent”), entitled “Formulation of Boronic External link to document
2012-11-19 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,713,446 B2; 6,958,319 B2;. … 24 September 2015 1:12-cv-01490 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.